Article
Medicine, General & Internal
Marc Agea Martinez, Raul Antunez-Conde, Carlos Navarro Cuellar, Manuel Tousidonis Rial, Ignacio Navarro Cuellar, Ana Maria Lopez Lopez, Dafne Gascon Alonso, Angela Sada Urmeneta, Jose J. Zamorano-Leon
Summary: This study evaluated the functional outcomes and quality of life in patients with intraoral defects reconstructed with the buccinator myomucosal flap. The results showed that most patients had satisfactory function and aesthetics after the reconstruction, but radiotherapy had a negative impact on quality of life.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Oncology
Nern Hoong Kao, N. Gopalakrishna Iyer, Alice Chua, Rahul Harshad Nagadia
Summary: This study evaluated the quality of life of head and neck cancer survivors after surgical treatment, specifically focusing on eating-related concerns. Factors such as advanced tumor stage, extent of surgery, and adjuvant treatment were found to be associated with lower overall health scores. Improvement in quality of life was observed in previous studies after one year.
SUPPORTIVE CARE IN CANCER
(2022)
Article
Nutrition & Dietetics
Ylva Tiblom Ehrsson, Per Fransson, Sandra Einarsson
Summary: The study showed that nutrition status is closely related to health-related quality of life, anxiety, and depression in head and neck cancer patients. More patients reported anxiety at the beginning of treatment, while more reported depression at seven weeks. Targeted support is needed during care, and long-term survivors need strategies to cope with the consequences.
Article
Health Care Sciences & Services
Deyu Huang, Dingfen Zeng, Yuan Tang, Longlin Jiang, Qing Yang
Summary: This study developed mapping algorithms for thyroid cancer patients in China, which can predict health utility scores. By using the EORTC QLQ-C30 and QLQ H&N35 scales, along with variables such as age and gender, the best predictive models were determined.
QUALITY OF LIFE RESEARCH
(2023)
Article
Cardiac & Cardiovascular Systems
Markus S. Anker, Sophia K. Potthoff, Alessia Lena, Jan Porthun, Sara Hadzibegovic, Ruben Evertz, Corinna Denecke, Ann-Kathrin Froehlich, Frederike Sonntag, Vera Regitz-Zagrosek, Stuart D. Rosen, Alexander R. Lyon, Thomas F. Luescher, John A. Spertus, Stefan D. Anker, Mahir Karakas, Lars Bullinger, Ulrich Keller, Ulf Landmesser, Javed Butler, Stephan von Haehling
Summary: This study compared the EORTC QLQ-C30 and ESC HeartQoL questionnaires for assessing health-related quality of life in cancer patients, and found that both instruments were associated with increased mortality in cancer patients. Combining both questionnaires provided even greater stratification of patient risk.
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Article
Medicine, General & Internal
Rachel S. van Leeuwaarde, Angelica M. Gonzalez-Clavijo, Marc Pracht, Galina Emelianova, Winson Y. Cheung, Christina Thirlwell, Kjell Oberg, Francesca Spada
Summary: This study aims to assess patients' perceptions of the EORTC QLQ-C30 and EORTC QLQ-G.I.NET21 questionnaires in neuroendocrine neoplasms (NENs). The study found that there are limitations in the design of the questions and the patients' satisfaction reporting of the questionnaire.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Nutrition & Dietetics
Elwira Gliwska, Dominika Glabska, Zuzanna Zaczek, Jacek Sobocki, Dominika Guzek
Summary: Patients with cancers of the head and neck and upper gastrointestinal tract are susceptible to malnutrition, which impacts their quality of life. Factors such as weight loss, group type, and age play a significant role in influencing patients' quality of life.
Article
Multidisciplinary Sciences
Mikiyas Amare Getu, Panpan Wang, Eva Johanna Kantelhardt, Edom Seife, Changying Chen, Adamu Addissie
Summary: This study aimed to examine the validity and reliability of the EORTC QLQ-BR45 questionnaire among breast cancer patients in Ethiopia. The results showed that the questionnaire has good reliability and validity, and can be used to assess the quality of life of breast cancer patients.
SCIENTIFIC REPORTS
(2022)
Article
Oncology
Malin Berg, Ewa Silander, Mogens Bove, Leif Johansson, Jan Nyman, Eva Hammerlid
Summary: The study of 311 HNC patients found that older patients (70 years and older) receiving curative treatment have similar or even better health-related quality of life (HRQOL) compared to younger adult patients during the first year after treatment, except for differences in physical function. Most HRQOL scores were equal or better for older patients at 3 months after treatment, but physical function was better for younger patients up to 12 months after treatment.
JOURNAL OF GERIATRIC ONCOLOGY
(2022)
Article
Oncology
Michele Reni, Julia Braverman, Andrew Hendifar, Chung-Pin Li, Teresa Macarulla, Do-Youn Oh, Hanno Riess, Margaret Tempero, Brian Lu, James Marcus, Namita Joshi, Marc Botteman, Amylou C. Dueck
Summary: The study calculated the minimal important difference (MID) and responder definition (RD) of EORTC QLQ-PAN26 questionnaire in patients with pancreatic cancer who received adjuvant chemotherapy in the APACT trial. Results showed that anchor-based MIDs were twice as sensitive as distribution-based MIDs in detecting group-level changes in QLQ-PAN26 scales/items.
ANNALS OF SURGICAL ONCOLOGY
(2021)
Article
Medicine, General & Internal
Austin J. Iovoli, Lauren Turecki, Michelle L. Qiu, Michael Khan, Kelsey Smith, Han Yu, Sung Jun Ma, Mark K. Farrugia, Anurag K. Singh
Summary: Oral mucositis is a common adverse effect in head and neck cancer patients receiving radiation therapy. This study aimed to investigate the associations between the severity of oral mucositis and clinical outcomes and quality of life. The results showed that severe oral mucositis was associated with feeding tube placement, hospitalization, opiate use, and weight loss.
Article
Oncology
Suvina Amin, Seongjung Joo, Sandra Nolte, Hyun Kyoo Yoo, Nikunj Patel, Hilary F. Byrnes, Sara Costa-Cabral, Colin D. Johnson
Summary: This study systematically derived reference values for health-related quality of life (HRQoL) in metastatic pancreatic cancer (mPC) patients and found that patients in the POLO trial had better HRQoL scores compared to the literature and similar to the general population. These findings suggest the potential impact of prior treatment and resolution of chemotherapy-related symptoms on HRQoL in mPC patients.
Article
Oncology
O. Sjokvist, S. Hakansson, E. Pantiora, A. Karakatsanis
Summary: The study revealed that the HRQoL reference values for the outpatient breast clinic population were lower, with more severe symptoms and lower functionality compared to the general population. This suggests that the reference values may not accurately reflect the quality of life of the study population.
Article
Medicine, General & Internal
James W. F. Catto, Pramit Khetrapal, Federico Ricciardi, Gareth Ambler, Norman R. Williams, Tarek Al-Hammouri, Muhammad Shamim Khan, Ramesh Thurairaja, Rajesh Nair, Andrew Feber, Simon Dixon, Senthil Nathan, Tim Briggs, Ashwin Sridhar, Imran Ahmad, Jaimin Bhatt, Philip Charlesworth, Christopher Blick, Marcus G. Cumberbatch, Syed A. Hussain, Sanjeev Kotwal, Anthony Koupparis, John McGrath, Aidan P. Noon, Edward Rowe, Nikhil Vasdev, Vishwanath Hanchanale, Daryl Hagan, Chris Brew-Graves, John D. Kelly
Summary: This study compared the recovery and morbidity of patients undergoing robot-assisted radical cystectomy with intracorporeal reconstruction versus open radical cystectomy for bladder cancer. The results showed that robot-assisted surgery resulted in a statistically significant increase in the number of days alive and out of the hospital within 90 days of surgery. In addition, robot-assisted surgery had lower rates of thromboembolic and wound complications compared to open surgery. Patients who underwent robot-assisted surgery also reported better quality of life and less disability compared to those who underwent open surgery.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2022)
Article
Oncology
Laura A. Gray, Monica Hernandez Alava, Allan J. Wailoo
Summary: This study investigates the relationship between EQ-5D-3L and QLQ-C30 in breast cancer patients, providing a mapping model for cost-effectiveness analysis. Using a mixture model, QLQ-C30 scores were successfully converted to EQ-5D-3L scores, offering reliable estimates for economic evaluation of breast cancer health technologies.